Aurinia Pharmaceuticals AUPH Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's finite-lived intangible assets, accumulated amortization?
- Aurinia Pharmaceuticals (AUPH) reported finite-lived intangible assets, accumulated amortization of $16.83M in Q1 2026.
- How has Aurinia Pharmaceuticals's finite-lived intangible assets, accumulated amortization changed year-over-year?
- Aurinia Pharmaceuticals's finite-lived intangible assets, accumulated amortization increased by 5.3% year-over-year, from $15.99M to $16.83M.
- What is the long-term trend for Aurinia Pharmaceuticals's finite-lived intangible assets, accumulated amortization?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's finite-lived intangible assets, accumulated amortization has grown at a 12.8% compound annual growth rate (CAGR), from $9.12M to $16.62M.